[Pe-010] 一般演題ポスターセッション（英語）010

[Pe-010-2] The design of LUMINESCE: A phase 3 trial of satralizumab in patients with gMG

杉本 太路¹, Kaminski Henry², Zhao Chongbo³, zu Horste Gerd Meyer⁴, O’Connor Kevin C.⁵, Klingelschmitt Gaelle⁶, Krumova Petranka⁶, Bolt Stuart⁷, Vodopivec Ivana⁶, Lennon-Chrimes Sian⁷, 村井 弘之⁸ (1.Department of Clinical Neuroscience and Therapeutics, Hiroshima University, 2.Department of Neurology & Rehabilitation Medicine, George Washington University SMHS, 3.Department of Neurology, Huashan Hospital, Fudan University, 4.Department of Neurology, University Hospital of Munster, 5.Department of Neurology and Immunobiology, Yale University School of Medicine, 6.F. Hoffmann-La Roche Ltd, 7.Roche Products Ltd, 8.Department of Neurology, International University of Health and Welfare)